Disney To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Goldman Sachs boosted the price target for Tarsus Pharmaceuticals, Inc. TARS from $36 to $41. Goldman Sachs analyst Andrea Tan maintained a Neutral rating. Tarsus Pharmaceuticals shares closed at $46.65 on Thursday. See how other analysts view this stock.
Deutsche Bank boosted the price target for The Walt Disney Company DIS from $115 to $131. Deutsche Bank analyst Bryan Kraft maintained a Buy rating. Disney shares closed at $109.12 on Wednesday. See how other analysts view this stock.
Needham raised Agilysys, Inc. AGYS price target from $125 to $145. Needham analyst Mayank Tandon maintained a Buy rating. Agilysys shares settled at $120.84 on Wednesday. See how other analysts view this stock.
Needham cut Applied Materials, Inc. AMAT price target from $240 to $225. Needham analyst Charles Shi maintained a Buy rating. Applied Materials shares closed at $186.00 on Thursday. See how other analysts view this stock.
Piper Sandler boosted Mastercard Incorporated MA price target from $565 to $575. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating. Mastercard shares closed at $520.40 on Thursday. See how other analysts view this stock.
Benchmark boosted Tower Semiconductor Ltd. TSEM price target from $55 to $60. Benchmark analyst Cody Acree maintained a Buy rating. Tower Semiconductor shares closed at $46.30 on Thursday. See how other analysts view this stock.
Morgan Stanley cut the price target for SolarEdge Technologies, Inc. SEDG from $23 to $9. Morgan Stanley analyst Andrew Percoco downgraded the stock from Equal-Weight to Underweight. SolarEdge shares settled at $12.83 on Thursday. See how other analysts view this stock.
Baird boosted Biogen Inc. BIIB price target from $294 to $300. Baird analyst Brian Skorney maintained an Outperform rating. Biogen shares closed at $164.89 on Thursday. See how other analysts view this stock.
Baird raised the price target for Palo Alto Networks, Inc. PANW from $385 to $425. Baird analyst Shrenik Kothari maintained an Outperform rating. Palo Alto shares closed at $394.39 on Thursday. See how other analysts view this stock.
HC Wainwright & Co. cut Genelux Corporation GNLX price target from $32 to $30. HC Wainwright & Co. analyst Emily Bodnar maintained a Buy rating. Genelux shares closed at $2.94 on Thursday. See how other analysts view this stock.